BRCA2 and breast carcinoma: Supporting evidence for our findings is provided by a case–control study conducted by Górski et al. in the Polish population, where the BRCA2 C5972T (Met1915Thr) polymorphism was significantly associated with an increased risk of breast cancer, particularly among individuals carrying the homozygous genotype [19].